Levonorgestrel intrauterine system mirena: An update

Bangladesh Journal of Obstetrics and Gynecology

Volumn 23, Issue 1, 2008, Pages 25-31

  Siddiqui, Maruf ^a   Hossain, Fawzia ^b   Banu, Lailaa ^c  

^a Regional Spinal Injuries Centre   (United Kingdom)

^b BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^c BIRDEM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE;

ABDOMINAL CRAMP; ACNE; ADENOMYOSIS; AMENORRHEA; BACKACHE; BREAST TENDERNESS; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG INDUCED HEADACHE; DYSMENORRHEA; ENDOMETRIOSIS; FOOD AND DRUG ADMINISTRATION; HORMONAL CONTRACEPTION; HORMONE SUBSTITUTION; HUMAN; HYPERTHERMIC THERAPY; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; LOWER ABDOMINAL PAIN; MENORRHAGIA; MENSTRUAL IRREGULARITY; MOOD CHANGE; NAUSEA; PREMENSTRUAL SYNDROME; REVIEW; SIDE EFFECT; SPOTTING; UTERINE ARTERY EMBOLIZATION;

EID: 77949584788     PISSN: 10184287     EISSN: None     Source Type: Journal    
DOI: 10.3329/bjog.v23i1.3054     Document Type: Review

References (31)

1. Kumar P, Malhotra N. Jeffcoate's Principles of Gynaecology. Seventh International Edition. Jaypee Brothers 2008. P.816-818
2. Backman T. Benefit-risk assessment of the levonorgestrel intrauterine system in contraception. Drug Saf. 2004; 27(15):1185-204.
3. www.rxlist.com/cgi/generic/mirena.htm
4. www.coolnurse.com/mirena
5. Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. Update of: Cochrane Database Syst Rev. 2000;(2):CD002126.
6. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003855.
7. Lete I, Obispo C, Izaguirre F, Orte T, Rivero B, Cornellana MJ, Bermejo I, Obstetrics OB. The levonorgestrel intrauterine system (Mirena(R)) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction. Eur J Contracept Reprod Health Care. 2008 Apr 28:1-7.
8. Manetta LA, de Paula Martins W, Rosa E Silva JC, de Sá Rosa E Silva AC, Nogueira AA, Ferriani RA. Uterine Ultrasonographic changes during Endometriosis Treatment: A Comparison between LNG-IUD and a GnRH agonist. Ultrasound Med Biol. 2008 Jul 1.
9. Bahamondes L, Bahamondes MV, Monteiro I. Levonorgestrel-releasing intrauterine system: uses and controversies. Expert Rev Med Devices. 2008 Jul;5(4):437-445.
10. Küçük T, Ertan K. Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial. Clin Exp Obstet Gynecol. 2008;35(1):57-60.
11. Gupta HP, Singh U, Sinha S. Levonorgestrel intra-uterine system-a revolutionary intra-uterine device. J Indian Med Assoc. 2007 Jul;105(7):380, 382-5.
12. Kriplani A, Singh BM, Lal S, Agarwal N. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia. Int J Gynaecol Obstet. 2007 Jun;97(3):190-4.
13. Barrington JW, Bowen-Simpkins P. The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol. 1997 May;104(5):614-6.
14. Shaw RW, Symonds IM, Tamizian O, Chaplain J, Mukhopadhyay S. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. Aust N Z J Obstet Gynaecol. 2007 Aug;47(4):335-40.
15. Reid PC, Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. Br J Obstet Gynaecol 2005 Aug; 112(8):1121-5
16. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkilä A, Walker JJ, Cameron IT. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol. 1998 Jun;105(6):592-8.
17. Tam WH, Yuen PM, Shan Ng DP, Leung PL, Lok IH, Rogers MS :Health status function after treatment with thermal balloon endometrial ablation and levonorgestrel intrauterine system for idiopathic menorrhagia: a randomized study. Gynecol Obstet Invest. 2006;62(2):84-8. Epub 2006 Apr 11.
18. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivelä A, Kujansuu E, Vuorma S, Yliskoski M, Paavonen J. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA. 2004 Mar 24;291(12):1456-63.
19. Rönnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand. 1999 Sep;78(8):716-21.
20. th AGM & national Scientific Conference of OGSB. June 19-20, 2008, Dhaka.
21. Wildemeersch D, Schacht E. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Eur J Contracept Reprod Health Care. 2001 Jun;6(2):93-101.
22. Wildemeersch D, Schacht E. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Eur J Obstet Gynecol Reprod Biol. 2002 Apr 10;102(1):74-9
23. Wildemeersch D, Schacht E, Wildemeersch P. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Eur J Contracept Reprod Health Care. 2001 Dec;6(4):192-8.
24. Wildemeersch D, Schacht E. Contraception with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Eur J Contracept Reprod Health Care. 2000 Dec;5(4):234-40
25. Wildemeersch D, Schacht E. Endometrial suppression with a new 'frameless' levonorgestrel releasing intrauterine system in perimenopausal and postmenopausal women: a pilot study. Maturitas. 2000 Jul 31;36(1):63-8.
26. Lethaby AE, Cooke I, Rees M. Progesterone/ progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005;(4):CD002126.
27. Hendlish SK, Horowicz-Mehler NC, Brixner DI, Stern LS, Doyle JJ, Chang J, Hagan M. Contraceptive and noncontraceptive benefits of the LNG-IUS in a vertically integrated HMO. Contraception. 2008 Jul;78(1):36-41.
28. Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)] Minerva Ginecol. 2002 Jun;54(3):271-8..
29. Luukkainen T, Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception. 1995 Nov;52(5):269-76
30. Rybo G, Andersson K, Odlind V. Hormonal intrauterine devices. Ann Med. 1993 Apr;25(2):143-7.
31. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception. 1994 Jan;49(1):56-72.